Tenax Therapeutics, Inc. (TENX)
1.98
+0.05
(+2.59%)
USD |
NASDAQ |
Oct 02, 16:00
1.97
-0.01
(-0.51%)
After-Hours: 20:00
Tenax Therapeutics EPS Diluted (Quarterly) : -0.35 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.35 |
| March 31, 2026 | -0.3475 |
| December 31, 2025 | -0.3798 |
| September 30, 2025 | -0.3977 |
| June 30, 2025 | -0.2741 |
| March 31, 2025 | -0.2845 |
| December 31, 2024 | -0.1776 |
| September 30, 2024 | -0.1872 |
| June 30, 2024 | -1.826 |
| March 31, 2024 | -3.116 |
| December 31, 2023 | -10.81 |
| September 30, 2023 | -6.611 |
| June 30, 2023 | -4.002 |
| March 31, 2023 | -12.10 |
| December 31, 2022 | -88.98 |
| September 30, 2022 | -177.23 |
| June 30, 2022 | -181.60 |
| March 31, 2022 | -172.75 |
| December 31, 2021 | -203.79 |
| September 30, 2021 | -241.17 |
| June 30, 2021 | -159.55 |
| March 31, 2021 | -2617.76 |
| December 31, 2020 | -358.78 |
| September 30, 2020 | -285.87 |
| June 30, 2020 | -367.74 |
| Date | Value |
|---|---|
| March 31, 2020 | -609.01 |
| December 31, 2019 | -662.53 |
| September 30, 2019 | -527.79 |
| June 30, 2019 | -441.39 |
| March 31, 2019 | -529.54 |
| December 31, 2018 | -9393.57 |
| September 30, 2018 | -1680.75 |
| June 30, 2018 | -2055.55 |
| March 31, 2018 | -1341.49 |
| December 31, 2017 | -1522.88 |
| September 30, 2017 | -1280.00 |
| June 30, 2017 | -3520.00 |
| March 31, 2017 | -3840.00 |
| December 31, 2016 | -33600.00 |
| September 30, 2016 | -4800.00 |
| June 30, 2016 | -5440.00 |
| July 31, 2015 | -3520.00 |
| April 30, 2015 | -5675.20 |
| January 31, 2015 | -3200.00 |
| October 31, 2014 | -4480.00 |
| July 31, 2014 | -2560.00 |
| April 30, 2014 | -12032.96 |
| January 31, 2014 | -14080.00 |
| October 31, 2013 | -40000.00 |
| July 31, 2013 | -107520.0 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Exicure, Inc. | -0.1759 |
| Century Therapeutics, Inc. | -0.1679 |
| Absci Corp. | -0.2109 |
| Celularity, Inc. | 0.0223 |
| Cardio Diagnostics Holdings, Inc. | -0.5073 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.80M |
| Total Expenses (Quarterly) | 17.80M |
| Enterprise Value | -54.72M |
| Earnings Yield | -74.49% |
| Normalized Earnings Yield | -74.49 |